Item 1.01 Entry into a Material Definitive Agreement.





Final Court Order

On October 19, 2021, Instadose Pharma Corp ("Instadose Canada" or the "Petitioner") applied to the Supreme Court of British Columbia (the "Court") in connection with a proposed plan of arrangement (the "Plan of Arrangement") giving effect to an arrangement (the "Arrangement") under section 288 of the Business Corporations Act (British Columbia), S.B.C. 2002, c.57, as amended, (the "BCBCA") involving the Petitioner, its shareholders and Instadose Pharma Corp. (formerly Mikrocoze Inc.) ("MZKR").

Instadose Canada received a Final Order which provided for, among others, (i) pursuant to Section 291 (4)(c) of the BCBCA the Arrangement as provided for in the Plan of Arrangement, including the terms and conditions thereof and the distributions, issuances, exchanges and/or adjustments of securities contemplated therein or in connection therewith, is procedurally and substantively fair and reasonable to the Instadose Shareholders; and (ii) pursuant to section 291(4)(a) of the BCBCA, the Arrangement as provided for in the Plan of Arrangement, including the terms and conditions thereof and the distributions, issuances, exchanges, and/or adjustments of securities contemplated therein or in connection therewith, be and was hereby approved by the Court.

Closing of the Arrangement is expected to occur on or about November 15, 2021.

The foregoing description of the Final Order and the transactions contemplated thereby does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Final Order, a copy of which is attached as Exhibit 2.2 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description
    2.2         Final Order issued by the Supreme Court of British Columbia, dated
              October 19, 2021, In the Mater of Section 228 of the British
              Corporations Act (British Columbia), S.B.C 2002, C. 57, as amended,
              and in the matter of an Arrangement Involving Instadose Pharma
              Corp., its Shareholders, and Instadose Pharma Corp. (formerly
              Mikrocoze Inc.)
    104       Cover Page Interactive Data File (formatted as Inline XBRL)





2

© Edgar Online, source Glimpses